Recombinant Antibody Market Report

Global and Region Recombinant Antibody Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：214
  • REPORT CODE：GMM1013591
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Recombinant antibodies are antibody fragments produced by synthetic genes. Recombinant antibodies are used in medical and research applications. Recombinant antibodies in different formats are used in human and pharmaceutical research and production.

    The global recombinant antibody production market is divided into five key regions. North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to lead the global recombinant antibody production market. Europe also shows the second largest market in the recombinant antibody production market. The massive R&D expenditures in the development of new drugs in developed regions, coupled with the emergence of large companies in the fields of biotechnology and molecular science, are driving the growth of the recombinant antibody production market in North America and Europe. It is expected that the recombinant antibody production market in the Asia-Pacific region will see significant growth in the next few years.

    Increasing research and development in the biopharmaceutical industry is expected to promote the growth of the recombinant antibody production market. Manufacturers are focusing on the production of new antibodies, which is expected to promote the growth of the recombinant antibody production market. The rapid growth of the biopharmaceutical industry is expected to create strong growth opportunities for the recombinant antibody production market. The high demand for recombinant antibodies in the diagnosis and treatment of various diseases is expected to drive the growth of the recombinant antibody production market. Recombinant antibodies have become a treatment for cancer, HIV, and herpes simplex virus. Compared with full-length IgG immunoglobulins, advantages such as better penetration in tumor tissues are expected to benefit the growing recombinant antibody production market.

    The report details the trend, potential and market size of Recombinant Antibody market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Antibodymarket, defines the market attractiveness level of Recombinant Antibody market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Antibody industry, describes the types of Recombinant Antibody market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Antibody market and the development prospects and opportunities of Recombinant Antibody industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Antibody market in Chapter 13.

    By Player:

    • Bioventix

    • GE Healthcare

    • Abnova

    • Medix Biochemica

    • SinoBiological

    By Type:

    • Single Chain Variable Fragment (scFv)

    • Fab Fragment

    • Bispecific Recombinant Antibodies (Diabodies)

    By End-User:

    • Hospital

    • Scientific Research

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Antibody Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Antibody Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Antibody Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Antibody Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Antibody Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Antibody Consumption (2017-2022)

    • 7.2 United States Recombinant Antibody Consumption (2017-2022)

    • 7.3 Europe Recombinant Antibody Consumption (2017-2022)

    • 7.4 China Recombinant Antibody Consumption (2017-2022)

    • 7.5 Japan Recombinant Antibody Consumption (2017-2022)

    • 7.6 India Recombinant Antibody Consumption (2017-2022)

    • 7.7 South Korea Recombinant Antibody Consumption (2017-2022)

    8 Region and Country-wise Recombinant Antibody Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Antibody Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Antibody Consumption Forecast (2022-2028)

    9 Global Recombinant Antibody Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Antibody Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Single Chain Variable Fragment (scFv) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Fab Fragment Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Bispecific Recombinant Antibodies (Diabodies) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Antibody Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Scientific Research Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Antibody Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Antibody Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Single Chain Variable Fragment (scFv) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Fab Fragment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Bispecific Recombinant Antibodies (Diabodies) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Antibody Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Antibody Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Antibody Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Antibody Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Antibody Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Antibody Market Competitive Analysis

    • 14.1 Bioventix

      • 14.1.1 Bioventix Company Details

      • 14.1.2 Bioventix Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bioventix Recombinant Antibody Product and Service

    • 14.2 GE Healthcare

      • 14.2.1 GE Healthcare Company Details

      • 14.2.2 GE Healthcare Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GE Healthcare Recombinant Antibody Product and Service

    • 14.3 Abnova

      • 14.3.1 Abnova Company Details

      • 14.3.2 Abnova Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abnova Recombinant Antibody Product and Service

    • 14.4 Medix Biochemica

      • 14.4.1 Medix Biochemica Company Details

      • 14.4.2 Medix Biochemica Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Medix Biochemica Recombinant Antibody Product and Service

    • 14.5 SinoBiological

      • 14.5.1 SinoBiological Company Details

      • 14.5.2 SinoBiological Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 SinoBiological Recombinant Antibody Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Antibody

    • Figure Recombinant Antibody Picture

    • Table Global Recombinant Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Antibody Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Antibody Consumption by Country (2017-2022)

    • Figure United States Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Antibody Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Single Chain Variable Fragment (scFv) Consumption and Growth Rate (2017-2022)

    • Figure Global Fab Fragment Consumption and Growth Rate (2017-2022)

    • Figure Global Bispecific Recombinant Antibodies (Diabodies) Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Scientific Research Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Single Chain Variable Fragment (scFv) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fab Fragment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bispecific Recombinant Antibodies (Diabodies) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Antibody Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Antibody Export by Region (Top 5 Countries) (2017-2028)

    • Table Bioventix (Foundation Year, Company Profile and etc.)

    • Table Bioventix Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioventix Recombinant Antibody Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Recombinant Antibody Product and Service

    • Table Abnova (Foundation Year, Company Profile and etc.)

    • Table Abnova Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abnova Recombinant Antibody Product and Service

    • Table Medix Biochemica (Foundation Year, Company Profile and etc.)

    • Table Medix Biochemica Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medix Biochemica Recombinant Antibody Product and Service

    • Table SinoBiological (Foundation Year, Company Profile and etc.)

    • Table SinoBiological Recombinant Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table SinoBiological Recombinant Antibody Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US